Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation
Open Access
- 5 February 2007
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 39 (6), 373-375
- https://doi.org/10.1038/sj.bmt.1705587
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Roles of OX40 in the Pathogenesis and the Control of DiseasesInternational Journal of Hematology, 2006
- Mast cells in the development of adaptive immune responsesNature Immunology, 2005
- T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast CellsThe Journal of Immunology, 2004
- Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantationHistopathology, 2003
- Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skinArchives of Dermatological Research, 2002
- Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants1Transplantation, 2002
- Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantationBlood, 2001
- Mast cells as initiators of immunity and host defenseExperimental Dermatology, 2001
- Graft-versus-Host DiseaseNew England Journal of Medicine, 1991